Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lipella Pharmaceuticals, Inc. (LIPO)
NASDAQ:LIPO
RESEARCH TOOLSreports
Lipella Pharmaceuticals, Inc. (LIPO) Stock Price & Analysis
26 Followers
LIPO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.64 - $2.71
Previous Close$0.74
Volume15.05K
Average Volume (3M)60.73K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$3.29M
Total Debt (Recent Filing)$136.59K
Price to Earnings (P/E)-0.9
Beta-0.59
Next Earnings
May 15, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.80
Shares Outstanding6,250,034
10 Day Avg. Volume15,696
30 Day Avg. Volume60,729
Standard Deviation0.15
R-Squared0.04
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)1.49
Price to Sales (P/S)10.34
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$2.00Price Target Upside168.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Lipella Pharmaceuticals, Inc. News
Ownership Overview
28.26% Insiders
1.23% Mutual Funds
4.87% Other Institutional Investors
65.64% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LIPO FAQ
What was Lipella Pharmaceuticals, Inc.’s price range in the past 12 months?
Lipella Pharmaceuticals, Inc. lowest stock price was $0.64 and its highest was $2.71 in the past 12 months.
What is Lipella Pharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is Lipella Pharmaceuticals, Inc.’s upcoming earnings report date?
Lipella Pharmaceuticals, Inc.’s upcoming earnings report date is May 15, 2023 which is 356 days ago.
How were Lipella Pharmaceuticals, Inc.’s earnings last quarter?
Lipella Pharmaceuticals, Inc. released its earnings results on Mar 31, 2023. The company reported -$0.186 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.186.
Is Lipella Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Lipella Pharmaceuticals, Inc.’s price is currently Undervalued.
Does Lipella Pharmaceuticals, Inc. pay dividends?
Lipella Pharmaceuticals, Inc. does not currently pay dividends.
What is Lipella Pharmaceuticals, Inc.’s EPS estimate?
Lipella Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lipella Pharmaceuticals, Inc. have?
Lipella Pharmaceuticals, Inc. has 6,250,034 shares outstanding.
What happened to Lipella Pharmaceuticals, Inc.’s price movement after its last earnings report?
Lipella Pharmaceuticals, Inc. reported an EPS of -$0.186 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.622%.
Which hedge fund is a major shareholder of Lipella Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in LIPO
---
Lipella Pharmaceuticals, Inc. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.00 (168.78% Upside)
$2.00 (168.78% Upside)
Insider Transactions
Bought Shares
Worth $45.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.25%
12-Months-Change
Fundamentals
Return on Equity
-118.13%
Trailing 12-Months
Asset Growth
-39.88%
Trailing 12-Months
Company Description
Lipella Pharmaceuticals, Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company's lead product includes LP-10 and LP-310.
---
LIPO Stock 12 Months Forecast
Average Price Target
$2.00
▲(168.78% Upside)
Technical Analysis
BioCryst
―
Enanta Pharmaceuticals
―
Vertex Pharmaceuticals
―
Aurinia Pharmaceuticals
―
Best Analysts Covering LIPO
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+1.90%
initiated a buy rating 27 days ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +1.90% per trade.
---